RESEARCH TRIANGLE PARK, N.C.& SHERBROOKE, Quebec--(BUSINESS WIRE)--Aug. 10, 2006--Tranzyme Pharma, a leading biopharmaceutical company developing novel small molecule therapeutics for the treatment of gastrointestinal (GI) and metabolic diseases, announced today the appointment of Eric M. Nelson, Ph.D., as the Company’s Vice President of Business Development & Licensing.
